Evaluation of population‐level pharmacogenetic actionability in Alabama

Abstract The evolution of evidence and availability of Clinical Pharmacogenetic Implementation Consortium (CPIC) guidelines have enabled assessment of pharmacogenetic (PGx) actionability and clinical implementation. However, population‐level actionability is not well‐characterized. We leveraged the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brittney H. Davis, Kelly Williams, Devin Absher, Bruce Korf, Nita A. Limdi
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/d2f206528b0f46e5aa0f3e0e2001aa3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!